Gilead wins European approval for HIV prevention injection

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/30/2026

1. META
2. MSFT
3. V
4. SPY
5. STX
6. PYPL
7. KLAC
8. BE
9. QCOM
10. CSGP

Go back to Gilead wins European approval for HIV prevention injection
Gilead Sciences (NASDAQ: GILD) Delayed: 132.73 --0 (-0%)
Previous Close $132.73    52 Week High $108.63 
Open $132.73    52 Week Low $71.39 
Day High $132.73    P/E 73.33 
Day Low $132.73    EPS $1.81 
Volume 902